Literature DB >> 6039097

Ethambutol-isoniazid versus PAS-isoniazid in original treatment of pulmonary tuberculosis.

I D Bobrowitz, D E Robins.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 6039097     DOI: 10.1164/arrd.1967.96.3.428

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


× No keyword cloud information.
  8 in total

1.  Antituberculous therapy in pregnancy. Risks to the fetus.

Authors:  D J Scheinhorn; V A Angelillo
Journal:  West J Med       Date:  1977-09

Review 2.  Tuberculosis--chemotherapy.

Authors:  K M Citron
Journal:  Br Med J       Date:  1972-02-12

3.  Adverse reactions to daily and intermittent rifampicin regimens for pulmonary tuberculosis in Hong Kong.

Authors:  M Aquinas; W G Allan; P A Horsfall; P K Jenkins; W Hung-Yan; D Girling; R Tall; W Fox
Journal:  Br Med J       Date:  1972-03-25

4.  Modern management of tuberculosis.

Authors:  R C Young; A C Lindo; R L Hackney
Journal:  J Natl Med Assoc       Date:  1969-05       Impact factor: 1.798

5.  Therapy success and tuberculosis forms. A retrospective pilot study.

Authors:  R Prehn
Journal:  Pneumonologie       Date:  1976-11-04

6.  Adverse effects of antituberculosis drugs.

Authors:  D J Girling
Journal:  Drugs       Date:  1982 Jan-Feb       Impact factor: 9.546

7.  Ethambutol compared to rifampin in original treatment of pulmonary tuberculosis.

Authors:  I D Bobrowitz
Journal:  Lung       Date:  1980       Impact factor: 2.584

8.  Ethambutol MICs and MBCs for Mycobacterium avium complex and Mycobacterium tuberculosis.

Authors:  L B Heifets; M D Iseman; P J Lindholm-Levy
Journal:  Antimicrob Agents Chemother       Date:  1986-12       Impact factor: 5.191

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.